NCT06845098

Brief Summary

This project aims to study the effects of different types of thyroid surgery and RAIT on ovarian function and pregnancy outcomes of DTC women of childbearing age, analyze possible risk factors, and assess whether potential risk factors such as age, thyroid stimulating hormone (TSH) levels and positive thyroid antibodies are related to ovarian hypofunction and adverse pregnancy outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
32mo left

Started Feb 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Feb 2025Dec 2028

First Submitted

Initial submission to the registry

February 10, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

February 20, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 25, 2025

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

February 25, 2025

Status Verified

February 1, 2025

Enrollment Period

2.9 years

First QC Date

February 10, 2025

Last Update Submit

February 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • AMH level

    Measure the concentration of AMH in serum

    before treatment and 3, 6, 12 and 24 months after treatment

Secondary Outcomes (2)

  • Thyroid function

    before tratment and 3, 6, 12 and 24 months after treatment

  • clinical pregnancy rate

    up to 24 months after the treatment

Study Arms (3)

Thyroid one-sided lobe + isthmus resection

EXPERIMENTAL

Thyroid one-sided lobe + isthmus resection

Procedure: Thyroid one-sided lobe + isthmus resection

Total thyroidectomy

EXPERIMENTAL

Total thyroidectomy

Procedure: Total thyroidectomy

Total thyroidectomy + RAIT

EXPERIMENTAL

Total thyroidectomy + RAIT

Procedure: Total thyroidectomy + RAIT

Interventions

Total thyroidectomy

Total thyroidectomy

Total thyroidectomy + RAIT

Total thyroidectomy + RAIT

Thyroid one-sided lobe + isthmus resection

Thyroid one-sided lobe + isthmus resection

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20-45 years old;
  • Premenopausal women whose thyroid B-ultrasound + surgical pathology is clearly differentiated thyroid cancer (papillar thyroid cancer or follicular thyroid cancer);
  • TNM stage is in stage I (T1-3, N0 or N1, M0);
  • Treatment of thyroid tumor resection: unilateral lobe of the thyroid + isthmus resection, total thyroidectomy, total thyroidectomy + RAIT.

You may not qualify if:

  • Patients with malignant tumors in other parts or low undifferentiated thyroid cancer;
  • Patients with abnormal liver and kidney function;
  • TNM stage II and above;
  • History of ovarian surgery, hysterectomy, pelvic surgery or radiation therapy;
  • Pregnancy;
  • Have the following uterine abnormalities, such as uterine malformation (single-horned uterus, double uterus); untreated mediastinal uterus, submucosal uterine fibroids, multiple endometrial polyps, or severe uterine adhesion.
  • Patients diagnosed with polycystic ovary syndrome by the Rotterdam standard;
  • Patients with ovarian failure;
  • Patients have infectious factors, immune diseases and metabolic diseases that may affect pregnancy outcomes;
  • Pregnancy contraindications or diseases that have a clear impact on pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, 310000, China

Location

MeSH Terms

Conditions

Thyroid Diseases

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Study Officials

  • Minghua Ge

    Zhejiang Provincial People's Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2025

First Posted

February 25, 2025

Study Start

February 20, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

February 25, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations